Novel therapies.
Extremely preliminary results from uncontrolled feasibility studies hint that minocycline and T-cell cytolitic strategies deserve further evaluation in RA, as does the use of high-dose intravenous gammaglobulin in chronic cutaneous vasculitis.
Trentham
D E
DE
Harvard Medical School, Boston, Massachusetts.
D001172:Arthritis, Rheumatoid / Q000178:diet therapy / Q000628:therapy; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*